
|Articles|November 7, 2007
BIO issues white paper on comparative effectiveness
In a new paper, the Biotechnology Industry Organization reveals it has reservations about the use of comparative effectiveness in reviewing products.
Advertisement
The Biotechnology Industry Organization has issued a white paper on comparative effectiveness. Authored by BIO's director of economic policy Ted Buckley, Ph.D., the document maintains that while comparative effectiveness is a helpful tool for healthcare decision-makers when comparing different products, it cannot be used to provide one-size-fits-all answers. The report can be found on
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































